Correlation Between Reviva Pharmaceuticals and Protalix Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Protalix Biotherapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Protalix Biotherapeutics.

Diversification Opportunities for Reviva Pharmaceuticals and Protalix Biotherapeutics

0.55

Correlation Coefficient

Reviva Pharmaceuticals  Protalix Biotherapeutics

Very weak diversification

The 3 months correlation between Reviva and Protalix is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Protalix Biotherapeutics go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Protalix Biotherapeutics

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to generate 4.53 times more return on investment than Protalix Biotherapeutics. However, Reviva Pharmaceuticals is 4.53 times more volatile than Protalix Biotherapeutics. It trades about 0.08 of its potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.19 per unit of risk. If you would invest  19.00  in Reviva Pharmaceuticals Holdings on September 5, 2024 and sell it today you would lose (2.00) from holding Reviva Pharmaceuticals Holdings or give up 10.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Protalix Biotherapeutics

Reviva Pharmaceuticals

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Protalix Biotherapeutics

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Reviva Pharmaceuticals and Protalix Biotherapeutics

The main advantage of trading using opposite Reviva Pharmaceuticals and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.

The idea behind Reviva Pharmaceuticals Holdings and Protalix Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.